Stocks and Investing Stocks and Investing
Mon, November 15, 2021
Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021

Vamil Divan Maintained (BHVN) at Strong Buy with Decreased Target to $135 on, Nov 10th, 2021


Published on 2024-10-27 18:36:36 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "Biohaven Ltd." (BHVN) at Strong Buy with Decreased Target from $137 to $135 on, Nov 10th, 2021.

Vamil has made no other calls on BHVN in the last 4 months.



There are 7 other peers that have a rating on BHVN. Out of the 7 peers that are also analyzing BHVN, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $145 on, Tuesday, October 19th, 2021
  • Esther Rajavelu of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $109 on, Tuesday, August 10th, 2021


These are the ratings of the 5 analyists that currently disagree with Vamil


  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, October 6th, 2021
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $160 on, Wednesday, October 6th, 2021
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $156 on, Tuesday, October 5th, 2021
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $165 on, Monday, September 13th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Tuesday, August 3rd, 2021